全文获取类型
收费全文 | 4465篇 |
免费 | 467篇 |
国内免费 | 185篇 |
专业分类
耳鼻咽喉 | 19篇 |
儿科学 | 52篇 |
妇产科学 | 35篇 |
基础医学 | 253篇 |
口腔科学 | 51篇 |
临床医学 | 536篇 |
内科学 | 453篇 |
皮肤病学 | 20篇 |
神经病学 | 248篇 |
特种医学 | 63篇 |
外科学 | 222篇 |
综合类 | 804篇 |
一般理论 | 3篇 |
预防医学 | 1158篇 |
眼科学 | 20篇 |
药学 | 504篇 |
6篇 | |
中国医学 | 566篇 |
肿瘤学 | 104篇 |
出版年
2024年 | 8篇 |
2023年 | 89篇 |
2022年 | 118篇 |
2021年 | 229篇 |
2020年 | 260篇 |
2019年 | 177篇 |
2018年 | 179篇 |
2017年 | 189篇 |
2016年 | 158篇 |
2015年 | 182篇 |
2014年 | 336篇 |
2013年 | 346篇 |
2012年 | 276篇 |
2011年 | 289篇 |
2010年 | 251篇 |
2009年 | 232篇 |
2008年 | 252篇 |
2007年 | 216篇 |
2006年 | 180篇 |
2005年 | 169篇 |
2004年 | 147篇 |
2003年 | 119篇 |
2002年 | 91篇 |
2001年 | 65篇 |
2000年 | 57篇 |
1999年 | 48篇 |
1998年 | 32篇 |
1997年 | 31篇 |
1996年 | 29篇 |
1995年 | 27篇 |
1994年 | 26篇 |
1993年 | 34篇 |
1992年 | 26篇 |
1991年 | 25篇 |
1990年 | 19篇 |
1989年 | 19篇 |
1988年 | 18篇 |
1987年 | 16篇 |
1986年 | 17篇 |
1985年 | 20篇 |
1984年 | 23篇 |
1983年 | 17篇 |
1982年 | 16篇 |
1981年 | 10篇 |
1980年 | 11篇 |
1979年 | 15篇 |
1978年 | 10篇 |
1977年 | 3篇 |
1976年 | 5篇 |
1973年 | 3篇 |
排序方式: 共有5117条查询结果,搜索用时 15 毫秒
1.
轻度认知障碍(Mild cognition impairment, MCI)是尚未达到阿尔兹海默病(Alzheimer’s disease, AD)的诊断标准且可逆转为正常脑老化状态的最佳窗口期。情志异常、肝失疏泄(肝失疏泄日久致肝郁)已被证实为MCI的重要情志病机,且“长期负性情绪积累肝失疏泄致衰加速脑老化”的科学假说已在本课题组前期研究中得到初步证实,疏肝法干预肝郁型MCI患者疗效显著,但以上作用机制尚未得到完全阐述。因此本研究系统总结了中医学对MCI的认识,长期情绪不调肝失疏泄对MCI的影响及可能机制,疏肝解郁方药及其成分改善肝郁型MCI的可行性,并提出使用无束缚性设计的眼动技术以探索疏肝法改善肝郁型MCI的可行性,为MCI的中医药干预及其神经机制探讨提供新思路,为中医情志衰老学说增添新内涵。 相似文献
2.
Marc Evans MD Susanne Engberg MD Mads Faurby MSc João Diogo Da Rocha Fernandes MSc Pollyanna Hudson MSc William Polonsky PhD 《Diabetes, obesity & metabolism》2022,24(3):377-390
We designed a systematic literature review to identify available evidence on adherence to and persistence with antidiabetic medication in people with type 2 diabetes (T2D). Electronic screening and congress searches identified real-world noninterventional studies (published between 2010 and October 2020) reporting estimates of adherence to and persistence with antidiabetic medication in adults with T2D, and associations with glycaemic control, microvascular and/or macrovascular complications, hospitalizations and healthcare costs. Ninety-two relevant studies were identified, the majority of which were retrospective and reported US data. The proportions of patients considered adherent (median [range] 51.2% [9.4%-84.3%]) or persistent (median [range] 47.7% [16.9%-94.0%]) varied widely across studies. Multiple studies reported an association between greater adherence/persistence and greater reductions in glycated haemoglobin levels. Better adherence/persistence was associated with fewer microvascular and/or macrovascular outcomes, although there was little consistency across studies in terms of which outcomes were improved. More adherent and more persistent patients were typically less likely to be hospitalized or to have emergency department visits/admissions and spent fewer days in hospital annually than less adherent/persistent patients. Greater adherence and persistence were generally associated with lower hospitalization costs, higher pharmacy costs and lower or budget-neutral total healthcare costs compared with lower adherence/persistence. In conclusion, better adherence and persistence in people with T2D is associated with lower rates of microvascular and/or macrovascular outcomes and inpatient hospitalization, and lower or budget-neutral total healthcare expenditure. Education and treatment strategies to address suboptimal adherence and persistence are needed to improve clinical and economic outcomes. 相似文献
3.
4.
Sine Wichmann Martin Schønemann-Lund Anders Perner Theis S. Itenov Theis Lange Christian Gluud Rasmus E. Berthelsen Anne C. Brøchner Jørgen Wiis Morten H. Bestle 《Acta anaesthesiologica Scandinavica》2023,67(4):470-478
Background
Salt and water accumulation leading to fluid overload is associated with increased mortality in intensive care unit (ICU) patients, but diuretics' effects on patient outcomes are uncertain. In this first version of the GODIF trial, we aimed to assess the effects of goal-directed fluid removal with furosemide versus placebo in adult ICU patients with fluid overload.Methods
We conducted a multicentre, randomised, stratified, parallel-group, blinded, placebo-controlled trial in clinically stable, adult ICU patients with at least 5% fluid overload. Participants were randomised to furosemide versus placebo infusion aiming at achieving neutral cumulative fluid balance as soon as possible. The primary outcome was the number of days alive and out of the hospital at 90 days.Results
The trial was terminated after the enrolment of 41 of 1000 participants because clinicians had difficulties using cumulative fluid balance as the only estimate of fluid status (32% of participants had their initially registered cumulative fluid balance adjusted and 29% experienced one or more protocol violations). The baseline cumulative fluid balance was 6956 ml in the furosemide group and 6036 ml in the placebo group; on day three, the cumulative fluid balances were 1927 ml and 5139 ml. The median number of days alive and out of hospital at day 90 was 50 days in the furosemide group versus 45 days in the placebo group (mean difference 1 day, 95% CI -19 to 21, p-value .94).Conclusions
The use of cumulative fluid balance as the only estimate of fluid status appeared too difficult to use in clinical practice. We were unable to provide precise estimates for any outcomes as only 4.1% of the planned sample size was randomised. 相似文献5.
适宜性产区能够保障傣族药的品质,然而有关植物类傣族药适宜生态因子及适宜产区的研究目前较为匮乏。本研究利用中药材产地适宜性分析地理信息系统(GMPGIS)对植物类傣族药进行全国产地生态适宜性分析,首次提出了植物类傣族药主要分布区域的生态因子范围和主要土壤类型,如年均温8. 6~23. 7℃,年均降水量1 212~1 881 mm,年均日照149. 7~157. 4 W·m-2,主要土壤类型为强淋溶土、冲积土、高活性强酸土等。以179个采样点为基础,通过生态相似性分析得到植物类傣族药在全球范围内的最大生态相似度区域,主要包括中国、巴西、美国、缅甸、老挝等国家。在中国主要集中在云南的西部和南部,包括西双版纳傣族自治州、德宏傣族景颇族自治州普洱市、保山市、临沧市具有较大的适宜栽培区域。除此之外,本文通过分析傣族药人才匮乏、傣族药资源日益减少、文化传承具有局限性、科学研究薄弱等问题,并提出了通过傣族医药高素质人才培养、傣族药资源调研和保护工作、推进傣族药资料古籍的搜集整理、加强傣族药基础研究和应用研究等策略促进傣族医药发展。本研究为指导植物类傣族药生产基地合理布局、引种繁育等提供依据,为高品质傣族药的科学规范化生产奠定基础。 相似文献
6.
甘欣锦主任医师认为,滤泡性淋巴瘤乃本虚标实之证,以正气不足为本,痰毒瘀邪为标。在临床上,针对未达到西医治疗指征的滤泡性淋巴瘤患者,甘老师以“养正积自消”为治疗原则,扶正贯穿于治疗的始终,并加用抗肿瘤药物,以达扶正抗瘤之效。甘老师多采用补益药物充养先后天之本,从而改善肿瘤患者的虚损,以达阴平阳秘、气血调畅、正气充足的状态。甘老师常以主方为基础结合治疗变证的方法改善局部症状,并减轻放化疗、靶向治疗所带来的不良反应。临证时,在中医辨证的基础上结合辨病分层治疗,调节扶正与解毒的主次。另外,对于出现的各种变证当灵活化裁以改善症状,通过中医的治疗手段改善患者生活质量,延长患者生存时间。 相似文献
7.
探讨岗位价值评估方法在医院人力资源的管理过程中的应用和意义。采用国际岗位价值评估系统(IPE)对A医院现有140个岗位进行岗位价值评估,并利用岗位评分对人力资源管理问题进行剖析。A医院岗位评估分数的总趋势和总分布结果显示,岗位评估分值曲线现呈较平滑的递减趋势,这表明A医院职能处室内部各类岗位的岗位价值不存在明显差异。从各个职能处室内部来看,内部岗位评价结果分布比较均匀,说明部门内部分工相对合理。岗位价值评价有助于增强医院薪酬分配的公平性,提高薪酬的激励性,也有利于优化医院管理制度,推动医院可持续发展。 相似文献
8.
《Clinical therapeutics》2019,41(6):1040-1056.e3
PurposeCongenital cytomegalovirus (cCMV) infection is the most common congenital infection in the United States; however, limited data exist regarding the economic burden of cCMV disease (cCMVd) among newborns and infants. The purpose of this study was to compare health care resource utilization and costs between infants with cCMVd at birth and during the first year of life versus matched infants without diagnosed cCMVd.MethodsRetrospective analyses of health insurance claims data from the MarketScan Commercial Claims and Encounters and Multi-State Medicaid databases (January 1, 2011–December 31, 2016) were conducted. Infants with cCMV diagnosis (International Classification of Diseases, Ninth Revision, Clinical Modification code 771.1 or 078.5; International Classification of Diseases, Tenth Revision, Clinical Modification code P35.1 or B25) were included. Two mutually exclusive periods were examined: initial hospital stay at birth (“birth” analysis) and subsequent 12 months (“postbirth” analysis). Infants with cCMVd in both periods were matched 1:1 to infants without cCMVd based on demographic and clinical characteristics. All-cause costs for cCMVd in infants versus matched control infants were reported in 2016 US dollars. Multivariable regression analyses controlled for additional confounding factors.FindingsIn the birth analysis, 397 of 404 newborns with cCMVd (167 vaginal deliveries, 230 cesarean deliveries) were matched to control infants; newborns with cCMVd had an additional mean (95% CI) of 9.1 (5.8–12.3) and 9.0 (4.6–13.5) inpatient days and $24,274 (10,082–38,466) and $31,770 (9911–53,630) more unadjusted inpatient costs versus control infants for vaginal and cesarean deliveries, respectively. In the postbirth analysis, 678 of 679 infants with cCMVd were matched with control infants; infants with cCMVd had an additional $58,806 (95% CI, 41,247–76,365) in unadjusted costs versus control infants, with inpatient visits accounting for 85% of the difference. Newborns with cCMVd accrued costs at birth averaging 1.5 to 2.1 times greater than control infants for cesarean and vaginal deliveries. During the first year of life, infants with cCMVd had costs averaging 7 times greater than control infants.ImplicationscCMVd is associated with substantial economic burden from birth and during the first year of life. Our findings support the notion that developing effective prevention of cCMVd and increasing awareness of the disease among women should be a public health priority, given the economic burden of cCMVd. 相似文献
9.
《Clinical therapeutics》2019,41(11):2331-2342
PurposeNoninfectious inflammatory eye diseases (NIIEDs), such as uveitis, is a general term used to describe a complex mix of acute, chronic, allergic, and inflammatory disorders. Prior literature has established that, in addition to severe clinical burden, NIIEDs is associated with significant economic burden for US payers; however, no literature provides a current estimate of the economic burden associated with patients with high-cost NIIEDs. This study aimed to better understand the cost and resource use distribution and predictors of patients with high-cost NIIEDs.MethodsThis retrospective cohort study selected adult patients with NIIEDs from a large US administrative claims database between 2006 and 2015. Among the included patients, total all-cause health care costs were calculated for a randomly selected 12-month period. Patients in the top 20% of total all-cause health care costs were identified as high-cost patients; the remaining patients were identified as lower-cost patients. Patient demographic characteristics, clinical characteristics, cost, and health care resource utilization (HRU) were compared. Logistic regression models were used to determine characteristics associated with high-cost patients.FindingsPatients with NIIEDs (n = 14,879) were categorized into 2976 high-cost and 11,903 lower-cost patients. High-cost patients with NIIEDs were significantly more likely to experience blindness, cataract, cystoid macular degeneration, retinal detachment, and visual disturbances during the follow-up period than the lower-cost patients (all P < 0.05). The high-cost patients accounted for ~77% of the total all-cause health care spend. High-cost patients incurred an average annual total health care cost of $59,873, and the top 1 percentile incurred $349,967 during the follow-up period. Hospitalization was a key cost driver among the high-cost patients, accounting for 50% of the total cost among the top 1 percentile of patients. High-cost patients were more likely to have specific autoimmune diseases, inpatient admission, and use of biologic and immunosuppressant agents.ImplicationsA small segment of patients with NIIEDs consumed most resources. This study identified several predictors based on patient characteristics and HRU that may help inform the profile of patients with NIIEDs with the highest health care needs. As such, patients with a given profile can be selected for targeted interventions by clinicians to potentially help improve quality of care and to reduce costs. 相似文献
10.
Michelle Lerman Julia A. Gaebler Sunday Hoy Jessica Izhakoff Laura Gullett Timothy Niecko Pinar Karaca-Mandic Thomas ODonnell Stanley G. Rockson 《Journal of vascular surgery》2019,69(2):571-580